Instrument Inactif

Autres langues Abcam plc London S.E.

Actions

ABC

GB00B6774699

Produits pharmaceutiques

Autres langues

23/07	Abcam Limited Appoints Kaveh Kahen as Director, Effective July 14, 2026
18/06	ABCAM LIMITED Announces Termination of Markus Lusser as Director, Effective June 5, 2026
28/04	Wall Streets Rally wirkt angesichts steigender Inflationsrisiken fragiler
28/04	La racha de Wall Street se debilita ante el repunte de los riesgos inflacionistas
28/04	Wall Street's Rally Looks More Fragile as Inflation Risks Build
13/04	Abcam Launches SimpleStep Ignite ELISA
10/03	Abcam Limited Appoints Melanie Hammerschmidt-Broman as Director, Effective March 10, 2026
20/01	Abcam Joins the Innovative Health Initiative LIGAND-AI Project to Advance Artificial Intelligence (AI)-Driven Drug Discovery Through Open Science
12/01	Abcam Limited Announces Termination of Knud Mueller as Director, Effective December 31, 2025
21/10/25	Molecular Instruments and Abcam Announce Broad Compatibility of the HCR HiFi Encoder with Abcam?s Rabmab and Mouse Antibody Portfolio
06/12/23	Global markets live: Mastercard, Diageo, Nvidia, Airbnb, Exxon Mobil...
06/12/23	Job losses delight investors
06/12/23	Danaher Closes Acquisition of Abcam
06/12/23	Danaher completes $5.7 billion acquisition of Abcam
06/12/23	Danaher Completes Acquisition of Abcam
06/12/23	Abcam plc(NasdaqGS:ABCM) dropped from NASDAQ Composite Index
06/12/23	Abcam plc(NasdaqGS:ABCM) dropped from NASDAQ Biotechnology Index
06/12/23	Abcam plc(NasdaqGS:ABCM) dropped from S&P Global BMI Index
06/12/23	Danaher Corporation completed the acquisition of Abcam plc.
04/12/23	Abcam's Acquisition by Danaher Approved by UK Court
04/12/23	Acquisition of Abcam by Danaher Approved by the High Court of Justice of England and Wales
20/11/23	Abcam Acquisition by Danaher has received all Identified Clearances, Transaction Expected to Close on December 6, 2023
17/11/23	Abcam Says All Necessary Clearances for Acquisition by Danaher Obtained; Deal Set to be Completed on Dec. 6
17/11/23	Abcam Acquisition by Danaher Has Received All Identified Clearances; Transaction Expected to Close on December 6, 2023
07/11/23	All good things must come to an end